Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1124.2000 26.20 (2.39%)
NSE Oct 10, 2025 15:31 PM
Volume: 178.6K
 

logo
Jubilant Pharmova Ltd.
31 Oct 2017
1124.20
2.39%
buy
by ICICI Securities Limited
Target: 815
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 19% YoY to | 1642 crore (I-direct estimate: | 1716 crore). Revenues in the pharma segment grew 12% YoY to | 905 crore (I-direct estimate: | 934 crore) while life science ingredients (LSI) revenues grew 21% YoY to | 739 crore (I-direct estimate: | 755...
 
Jubilant Pharmova Ltd. has gained 35.76% in the last 6 Months
More from Jubilant Pharmova Ltd.
Recommended
Five Interesting Stocks Today - October 10, 2025
The Baseline | 10 Oct 2025, 05:09PM
Market closes higher, Capacit'e Infra bags Rs 542 cr order from IIT Bombay
Trendlyne Marketwatch | 10 Oct 2025, 04:01PM
Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
| 30 May 2020